Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum™ Next-Generation Protein Sequence Platform Output
Partnership Joins Protein Sequencing Technology With AI Visualization to Further Unlock the Human Proteome for Novel Drug Discovery
- This partnership combines Quantum-Si’s expertise in single molecule protein sequencing with Biovista’s AI visualization technology to facilitate faster and more efficient protein drug target discovery.
Biovista’s VIZIT™ exploration tool will be integrated into Quantum-Si’s cloud based suite of analytic tools enabling researchers to visualize the connections of their protein sequences identified during their experiment to diseases, other proteins, and post-translational modifications. This allows researchers to uncover potential mechanisms and biomarkers relevant to specific diseases more efficiently and effectively.
“Quantum-Si’s protein sequencing technology in concert with Biovista’s database and visualization technology can aid in the discovery of new proteins for future therapeutic targets associated with disease.” said
Biovista is a technology company developing new forms of AI to address major healthcare challenges. Having pioneered for the last 15 years AI-driven drug repositioning, proteomic-based insight generation, and clinical data analytics, the Company collaborates with market leaders to advance cost-effective healthcare solutions. Learn more at www.biovista.com.
Forward Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. The actual results of the Company may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations with respect to future performance and development and commercialization of products and services. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the Company's control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the impact of COVID-19 on the Company's business; the inability to maintain the listing of the Company's Class A common stock on
View source version on businesswire.com: https://www.businesswire.com/news/home/20230109005282/en/
Quantum-Si Media Contact